Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Oct 26;179:114021. doi: 10.1016/j.addr.2021.114021

Figure 5. Oral nanomedicine for targeting the lamina propria.

Figure 5.

Schematic illustration of TPP(sodium triphosphate)-PPM(a mannosylated bioreducible cationic polymer)/siRNA NP (NP) formation and macrophage-targeting delivery, and the release of siRNAs to the cytoplasm. Reproduced with permission from [162].